BRD-9327

• Description :

  BRD-9327 is an inhibitor of EfpA. BRD-9327 binds in the outer vestibule without complete blockade of the substrate path to the outside, suggesting its possible inhibition of the movement necessary for alternate access of the transporter. BRD-9327 can be used for anti-tuberculosis study[1].

• UNSPSC :

  12352005

• Target :

  Antibiotic

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Smiles :

  O=C(C1=CC=CCC1Br)NC2=CC3=C(OCCO3)C=C2C(C4=CC=CC=C4)=O

• Molecular Formula :

  C22H18BrNO4

• Molecular Weight :

  440.29

• References & Citations :

  [1]Khandelwal NK, et al. Structure and inhibition mechanisms of Mycobacterium tuberculosis essential transporter efflux protein A. Nat Commun. 2025 Apr 1;16 (1) :3139.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported